The antagonists of tumor necrosis factor alpha (TNF-α) are increasingly being used in the treatment of inflammatory and autoimmune diseases. Several adverse effects of these drugs have been reported, including the paradoxical development of sarcoidosis, especially with the use of etanercept. We present the first Brazilian case report of systemic sarcoidosis induced by etanercept and a literature review. © 2013 by Anais Brasileiros de Dermatologia.
CITATION STYLE
Unterstell, N., Bressan, A. L., Serpa, L. A., da Castro, P. P. F., & Gripp, A. C. (2013). Sarcoidose sistêmica induzida por etanercepte: Primeiro relato de caso brasileiro. Anais Brasileiros de Dermatologia, 88(6 SUPPL.1), 197–199. https://doi.org/10.1590/abd1806-4841.20132588
Mendeley helps you to discover research relevant for your work.